Optimizing Adjuvant Treatment Decisions for Stage T2 Rectal Cancer Based on Mesorectal Node Size-Reference-Cited by-同舟云学术

Optimizing Adjuvant Treatment Decisions for Stage T2 Rectal Cancer Based on Mesorectal Node Size

Published:2013-01 Issue:1 Volume:20 Page:79-89
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Hartman Rebecca I.,Chang Connie Y.,Wo Jennifer Y.,Eisenberg Jonathan D.,Hong Theodore S.,Harisinghani Mukesh G.,Gazelle G. Scott,Pandharipande Pari V.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference34 articles.

1. American Cancer Society. Cancer facts and figures 2012. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf. Accessed April 28, 2012.

2. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona 2007;Van Cutsem;Ann Oncol,2008

3. Preoperative versus postoperative chemoradiotherapy for rectal cancer;Sauer;N Engl J Med,2004

4. Rectal cancer: Preoperative versus postoperative irradiation as a component of adjuvant treatment;Gunderson;Semin Radiat Oncol,2003

5. Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2);Valentini;Radiother Oncol,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging Strategies for Rectal Cancer Initial Staging: Does Pelvic Computed Tomography Provide Significantly Additional Findings when High-resolution Magnetic Resonance Imaging has Been Performed?;Current Medical Imaging Formerly Current Medical Imaging Reviews;2020-10-18